Alyeska Investment Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,202,779
| Closed | -$121M | – | 571 |
|
|
2025
Q1 | $121M | Sell |
1,202,779
-438,655
| -27% | -$44.3M | 0.48% | 56 |
|
|
2024
Q4 | $147M | Buy |
1,641,434
+1,271,434
| +344% | +$114M | 0.55% | 34 |
|
|
2024
Q3 | $31M | Sell |
370,000
-92,803
| -20% | -$7.78M | 0.16% | 191 |
|
|
2024
Q2 | $35.6M | Sell |
462,803
-1,159,646
| -71% | -$89.3M | 0.2% | 138 |
|
|
2024
Q1 | $111M | Sell |
1,622,449
-738,912
| -31% | -$50.6M | 0.68% | 35 |
|
|
2023
Q4 | $137M | Buy |
2,361,361
+201,428
| +9% | +$11.6M | 0.9% | 20 |
|
|
2023
Q3 | $114M | Buy |
2,159,933
+1,459,933
| +209% | +$77.1M | 0.77% | 24 |
|
|
2023
Q2 | $37.9M | Buy |
+700,000
| New | +$37.9M | 0.28% | 117 |
|
|
2021
Q1 | – | Sell |
-42,040
| Closed | -$1.51M | – | 728 |
|
|
2020
Q4 | $1.51M | Buy |
+42,040
| New | +$1.51M | 0.02% | 386 |
|
|
2019
Q3 | – | Sell |
-27,357
| Closed | -$1.18M | – | 375 |
|
|
2019
Q2 | $1.18M | Buy |
+27,357
| New | +$1.18M | 0.02% | 328 |
|
|
2017
Q2 | – | Sell |
-210,199
| Closed | -$5.23M | – | 432 |
|
|
2017
Q1 | $5.23M | Sell |
210,199
-2,275,001
| -92% | -$56.6M | 0.04% | 299 |
|
|
2016
Q4 | $53.8M | Buy |
+2,485,200
| New | +$53.8M | 0.44% | 70 |
|